bioMérieux Launches GENE-UP® TYPER SLM to Strengthen Food Safety Testing

New PCR Solution Targets Rapid Salmonella Source Identification

On June 18, 2026, bioMérieux announced the global launch of GENE-UP® TYPER SLM, a new real-time PCR solution designed to support rapid root cause analysis of Salmonella contamination in food production environments. The innovative assay enables food manufacturers to quickly differentiate and characterize Salmonella strains, helping identify contamination sources and improve food safety management. The launch reflects the company's continued commitment to advancing molecular diagnostic technologies for industrial applications.

According to Towards Healthcare, the France in-vitro diagnostics market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 3.33 billion in 2026 to approximately USD 5.56 billion by 2035, representing a compound annual growth rate (CAGR) of 5.85% from 2026 to 2035. This growth is supported by expanding diagnostic applications, increasing prevalence of chronic diseases, favorable healthcare policies, and continuous investments in innovative testing technologies and laboratory infrastructure.

Addressing a Major Global Food Safety Challenge

Salmonella remains one of the most significant foodborne pathogens worldwide, causing millions of infections annually. Contaminated food products can lead to serious public health concerns, costly product recalls, and reputational damage for food manufacturers. To mitigate these risks, companies increasingly rely on advanced diagnostic tools capable of detecting contamination events and identifying their origins. GENE-UP® TYPER SLM was developed specifically to address these challenges by providing rapid and actionable insights for contamination investigations.

Combining Genomics and Machine Learning

The new assay is designed to identify Salmonella enterica subspecies enterica, the strain most frequently associated with foodborne illness. Following routine pathogen detection and DNA extraction, the solution generates analytical results that are uploaded to bioMérieux's AUGMENTED-DX platform. The system leverages machine learning algorithms and an extensive genomic database to assign unique strain identifiers and group related strains into clusters. This process allows manufacturers to establish historical contamination patterns and trace contamination sources more effectively across production facilities.

Expanding Innovation in Food Diagnostics

The launch builds on the successful introduction of the GENE-UP® TYPER platform in 2025, which initially focused on Listeria monocytogenes detection. Developed in collaboration with Mérieux NutriSciences, the patented solution is now available worldwide. The innovation highlights growing demand for advanced molecular diagnostics, genomics, and data-driven technologies that support food safety, quality assurance, and operational efficiency throughout the food manufacturing industry. 

According to Towards Healthcare, the France in-vitro diagnostics market is driven by increasing demand for early disease detection, technological advancements in diagnostic testing, rising healthcare expenditure, and growing adoption of personalized medicine across the country.